Clinical Trials
11
Active:4
Completed:0
Trial Phases
4 Phases
Phase 1:3
Phase 2:2
Phase 3:3
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (27.3%)Phase 1
3 (27.3%)Phase 3
3 (27.3%)Phase 2
2 (18.2%)A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis
Not Applicable
Not yet recruiting
- Conditions
- Atopic Dermatitis (AD)
- Interventions
- Biological: MG-K10 placebo
- First Posted Date
- 2025-08-05
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT07103174
- Locations
- 🇨🇳
Tower 5,No.34,Chunxiao Road No.122 Pudong District, Shanghai, 201203.p R. china, Shanghai, Shanghai, China
🇨🇳Hangzhou First People's Hospital, Zhejiang, 杭州, China
Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects
Not Applicable
Active, not recruiting
- Conditions
- Bronchial Asthma
- Interventions
- Drug: MG-ZG122 Humanized Monoclonal Antibody InjectionOther: Placebo
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 160
- Registration Number
- NCT07054034
- Locations
- 🇨🇳
China-Japan Friendship Hospital, Beijing, China, Beijing, Beijing, China
Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Phase 2
Recruiting
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Biological: MG-K10 Humanized Monoclonal Antibody InjectionBiological: Placebo
- First Posted Date
- 2025-02-26
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 160
- Registration Number
- NCT06846385
- Locations
- 🇨🇳
Beijing Tongren Hospital, Capital Medical University, Beijing, Beijing, China
Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Phase 3
Recruiting
- Conditions
- Asthma
- Interventions
- Drug: MG-K10/Placebo
- First Posted Date
- 2025-02-20
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 504
- Registration Number
- NCT06837922
- Locations
- 🇨🇳
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
Phase 3
Recruiting
- Conditions
- Prurigo Nodularis
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Shanghai Mabgeek Biotech.Co.Ltd
- Target Recruit Count
- 160
- Registration Number
- NCT06779136
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing,, Beijing, bejing, China
- Prev
- 1
- 2
- 3
- Next
News
No news found